StonvexLoading…
StonvexStonvexStonvexCore line items from JBTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.01B | $936.00M | $3.80B | $2.79B | $1.79B |
Operating Income | Not available | $68.00M | $189.40M | $117.10M | $15.00M |
Net Income | Not available | $45.00M | $-50.50M | $-103.60M | $-169.60M |
EPS (Diluted) | $1.99 | $0.86 | $-0.98 | $-2.00 | $-3.27 |
Total Assets | Not available | $8.16B | $8.19B | $8.20B | $8.25B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $230.00M | $167.90M | $133.30M | $130.00M |
Free Cash Flow OCF − CapEx | Not available | $93.00M | $238.10M | $154.60M | $98.10M |
Shares Outstanding | Not available | 52.40M | 52.00M | 51.90M | 51.97M |